PT Alone : Relies on mechanical stress to trigger healing
Amplitude O (Effect of Efpeglenatide on Cardiovascular Outcomes) revealed that patients with type 2 DM and CVD or kidney disease receiving once weekly efpeglenatide had a 27% lower incidence of the primary composite outcome and 32% lower risk of a composite renal outcome event compared to those receiving placebo [17]
It matters
174,175 In a randomized controlled three-month trial in 60 women with PCOS, participants were assigned to one of two energy-restricted diets, either DASH or a control
In patients with T2D, model outcome was mostly affected by eGFR followed by age and the serum concentrations of the uremic toxin p -cresol 30 and D -threitol, also indicative of kidney function 39
Zhang H, Panula S, Petropoulos S, Edsgrd D, Busayavalasa K, Liu L, et al